SCHEMBL2494339

SCHEMBL2494339

OCc1ccnc(-c2ccccc2)c1-c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.40
MAPT P10636 3/20 0.40
NPSR1 Q6W5P4 2/20 0.40
USP2 O75604 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
HSD17B10 Q99714 1/20 0.40
HTR2B P41595 1/20 0.40
HTR5A P47898 1/20 0.40
TDO2 P48775 1/20 0.40
LMNA P02545 2/20 0.40
TP53 P04637 1/20 0.40
TSHR P16473 1/20 0.40
ALOX12 P18054 1/20 0.40
CYP19A1 P11511 1/20 0.38
PDCD1 Q15116 1/20 0.38
CD274 Q9NZQ7 1/20 0.38
GAA P10253 1/20 0.37
NPC1 O15118 4/20 0.36
RAB9A P51151 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11772309 0.84 PDCD1 (0.42) KDM4EMAPTALDH1A1HPGDLMNA
SCHEMBL11772319 0.84 PDCD1 (0.42) KDM4EMAPTNPSR1USP2ALDH1A1
SCHEMBL11772864 0.83 ALDH1A1 (0.38) KDM4EMAPTNPSR1USP2ALDH1A1
SCHEMBL11772856 0.83 ALDH1A1 (0.41) KDM4EMAPTALDH1A1HPGDLMNA
SCHEMBL10878303 0.82 BCHE (0.41) NPC1RAB9AKMT2APDE3BPDE3A
SCHEMBL9052397 0.81 PTGS1 (0.38) KDM4EMAPTNPSR1HTR2BHTR5A
SCHEMBL5309860 0.81 HTR2B (0.37) KDM4EMAPTNPSR1ALDH1A1HPGD
SCHEMBL29986186 0.81 PTGS1 (0.46) MAPTALDH1A1HTR2BHTR5ATDO2
SCHEMBL11776623 0.80 PDCD1 (0.50) KDM4EMAPTLMNATP53TSHR
SCHEMBL11772326 0.79 BCHE (0.44) KDM4EMAPTALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH KDM4E 2772/4885MAPT 3454/4885NPSR1 1047/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 KDM4E 3096/4885MAPT 3294/4885NPSR1 1143/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R KDM4E 3125/4885MAPT 3128/4885NPSR1 1050/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.